Tvaster Genkalp, a Chennai-based startup, is revolutionizing cancer care with its non-invasive liquid biopsy test, Episcreen Liver, for early detection of hepatocellular carcinoma. Founded in 2021 by Srikar Raman and K Sreedurgalakshmi, the company has tested 1,400+ patients, raised $1.25M, and is driven by a mission to make advanced cancer diagnostics accessible.